Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Samir Parekh, Sundar Jagannath et al.|Cancer Cell|2021Cited by 216
Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myelomaAdolfo Aleman, Christian Cognigni, Maria C. Bermúdez‐González et al.|Cancer Cell|2021Cited by 76
Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patientsAdolfo Aleman, Samir Parekh, Oliver Van Oekelen et al.|Cancer Cell|2022Cited by 38